A small crossover trial favored midazolam over melatonin on sedation and satisfaction. Both were premedications before intravenous sedation, so the study did not compare either oral agent as the entire procedure regimen.
Twenty-three uncooperative children aged two to six received each premedication at separate dental visits. Midazolam was given thirty minutes before the intravenous stage and melatonin one hour before it. Structured behavior and physiologic measures accompanied satisfaction reports.
Sedation scores and satisfaction favored midazolam, while several monitored physiologic changes did not differ significantly.
The abstract reports more early nausea and vomiting with midazolam, but more tremor and dizziness with melatonin. The conclusion’s broader wording about dizziness does not align cleanly with that specific result. A summary should preserve the inconsistency.
A small crossover design can also carry experience from one dental visit into the next. The findings do not establish uncommon-event safety or a universal preference for all children.
Describe the complete sedation sequence, assessment times, and individual adverse outcomes. A premedication that improves cooperation before another sedative is administered has not thereby demonstrated standalone procedural efficacy, equivalent analgesia, or a better long-term behavioral outcome.
Original analysis of the supplied journal article, identified as PMC6397733.